Back to
Erste Asset Management GmbH
STOK
Showing 6 of 12 quarters
Position history for
Erste Asset Management GmbH's holdings in Stoke Therapeutics, Inc.
Yes. Erste Asset Management holds 428,381 shares of STOK (Stoke Therapeutics), worth $13.9M, as of its Q2 2026 13F filing. It reduced the position by 17,619 shares (-4.0%) from Q1 2026. Erste Asset Management has held STOK since Q1 2025, across 6 quarterly 13F filings. STOK is 0.1% of Erste Asset Management's reported 13F portfolio.
Current Value
$13.9M
Current Shares
428,381
Total Value Change
+$11.2M
Total Shares Change
+32,381
Quarter-by-Quarter History